Potential Tax Consequences of Cash Dividend PaymentClick Here to download PDF
01/19/17PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases
11/17/16PharmAthene Declares $2.91 Special Cash Dividend on Common Stock
11/16/16PharmAthene Receives Final Payment from SIGA of $83.9 Million
|Receive E-mail Alerts|
|Sign up to receive e-mail alerts whenever PharmAthene, Inc. posts new information to the site. Just enter your e-mail address and click Submit.|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|*PharmAthene, Inc. makes no representations or warranties with respect to the accuracy or completeness of the information provided herein and assumes no responsibility for correcting, updating, or supplementing any such information.|